欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1288/003
药品名称
Buprenorfina Teva
活性成分
buprenorphine hydrochloride 8.0 mg
剂型
Sublingual tablet
上市许可持有人
Teva Pharma - Produtos Farmacêuticos, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
许可日期
2015/07/10
最近更新日期
2020/01/15
药物ATC编码
N02AE01 buprenorphine
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
587481_587482_587483_20150817_PAR_IRS
Date of last change:2024/09/06
Final Product Information
|
Buprenorphine _PT_H_1288_001_003_PIL_final_clean
Date of last change:2024/09/06
Final Product Information
|
Buprenorphine PT_H_1288_001_003_labeling_outer_day160 clean
Date of last change:2024/09/06
Final Product Information
|
Buprenorphine PT_H_1288_001_003_SmPC_day160_clean
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase